A. Mehta
Australian National University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A. Mehta.
Journal of the American College of Cardiology | 2015
Rajeev K. Pathak; M. Middeldorp; Megan Meredith; A. Mehta; Rajiv Mahajan; Christopher X. Wong; D. Twomey; Adrian D. Elliott; Jonathan M. Kalman; Walter P. Abhayaratna; Dennis H. Lau; Prashanthan Sanders
BACKGROUND Obesity and atrial fibrillation (AF) frequently coexist. Weight loss reduces the burden of AF, but whether this is sustained, has a dose effect, or is influenced by weight fluctuation is unknown. OBJECTIVES This study sought to evaluate the long-term impact of weight loss and weight fluctuation on rhythm control in obese individuals with AF. METHODS Of 1,415 consecutive patients with AF, 825 had a body mass index ≥ 27 kg/m(2) and were offered weight management. After screening for exclusion criteria, 355 were included in this analysis. Weight loss was categorized as group 1 (≥ 10%), group 2 (3% to 9%), and group 3 (<3%). Weight trend and/or fluctuation was determined by yearly follow-up. We determined the impact on the AF severity scale and 7-day ambulatory monitoring. RESULTS There were no differences in baseline characteristics or follow-up among the groups. AF burden and symptom severity decreased more in group 1 compared with groups 2 and 3 (p < 0.001 for all). Arrhythmia-free survival with and without rhythm control strategies was greatest in group 1 compared with groups 2 and 3 (p < 0.001 for both). In multivariate analyses, weight loss and weight fluctuation were independent predictors of outcomes (p < 0.001 for both). Weight loss ≥ 10% resulted in a 6-fold (95% confidence interval: 3.4 to 10.3; p < 0.001) greater probability of arrhythmia-free survival compared with the other 2 groups. Weight fluctuation >5% partially offset this benefit, with a 2-fold (95% confidence interval: 1.0 to 4.3; p = 0.02) increased risk of arrhythmia recurrence. CONCLUSIONS Long-term sustained weight loss is associated with significant reduction of AF burden and maintenance of sinus rhythm. (Long-Term Effect of Goal directed weight management on Atrial Fibrillation Cohort: A 5 Year follow-up study [LEGACY Study]; ACTRN12614001123639).
Journal of the American College of Cardiology | 2015
Rajeev K. Pathak; Adrian D. Elliott; M. Middeldorp; Megan Meredith; A. Mehta; Rajiv Mahajan; Jeroen Hendriks; D. Twomey; Jonathan M. Kalman; Walter P. Abhayaratna; Dennis H. Lau; Prashanthan Sanders
BACKGROUND Obesity begets atrial fibrillation (AF). Although cardiorespiratory fitness is protective against incident AF in obese individuals, its effect on AF recurrence or the benefit of cardiorespiratory fitness gain is unknown. OBJECTIVES This study sought to evaluate the role of cardiorespiratory fitness and the incremental benefit of cardiorespiratory fitness improvement on rhythm control in obese individuals with AF. METHODS Of 1,415 consecutive patients with AF, 825 had a body mass index ≥27 kg/m(2) and were offered risk factor management and participation in a tailored exercise program. After exclusions, 308 patients were included in the analysis. Patients underwent exercise stress testing to determine peak metabolic equivalents (METs). To determine a dose response, cardiorespiratory fitness was categorized as: low (<85%), adequate (86% to 100%), and high (>100%). Impact of cardiorespiratory fitness gain was ascertained by the objective gain in fitness at final follow-up (≥2 METs vs. <2 METs). AF rhythm control was determined using 7-day Holter monitoring and AF severity scale questionnaire. RESULTS There were no differences in baseline characteristics or follow-up duration between the groups defined by cardiorespiratory fitness. Arrhythmia-free survival with and without rhythm control strategies was greatest in patients with high cardiorespiratory fitness compared to adequate or low cardiorespiratory fitness (p < 0.001 for both). AF burden and symptom severity decreased significantly in the group with cardiorespiratory fitness gain ≥2 METs as compared to <2 METs group (p < 0.001 for all). Arrhythmia-free survival with and without rhythm control strategies was greatest in those with METs gain ≥2 compared to those with METs gain <2 in cardiorespiratory fitness (p < 0.001 for both). CONCLUSIONS Cardiorespiratory fitness predicts arrhythmia recurrence in obese individuals with symptomatic AF. Improvement in cardiorespiratory fitness augments the beneficial effects of weight loss. (Evaluating the Impact of a Weight Loss on the Burden of Atrial Fibrillation [AF] in Obese Patients; ACTRN12614001123639).
Europace | 2018
M. Middeldorp; Rajeev K. Pathak; Megan Meredith; A. Mehta; Adrian D. Elliott; Rajiv Mahajan; D. Twomey; C. Gallagher; Jeroen Hendriks; Dominik Linz; R. Doug McEvoy; Walter P. Abhayaratna; Jonathan M. Kalman; Dennis H. Lau; Prashanthan Sanders
Aims Atrial fibrillation (AF) is a progressive disease. Obesity is associated with progression of AF. This study evaluates the impact of weight and risk factor management (RFM) on progression of the AF. Methods and results As described in the Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up (LEGACY) Study, of 1415 consecutive AF patients, 825 had body mass index ≥ 27 kg/m2 and were offered weight and RFM. After exclusion, 355 were included for analysis. Weight loss was categorized as: Group 1 (<3%), Group 2 (3-9%), and Group 3 (≥10%). Change in AF type was determined by clinical review and 7-day Holter yearly. Atrial fibrillation type was categorized as per the Heart Rhythm Society consensus. There were no differences in baseline characteristic or follow-up duration between groups (P = NS). In Group 1, 41% progressed from paroxysmal to persistent and 26% from persistent to paroxysmal or no AF. In Group 2, 32% progressed from paroxysmal to persistent and 49% reversed from persistent to paroxysmal or no AF. In Group 3, 3% progressed to persistent and 88% reversed from persistent to paroxysmal or no AF (P < 0.001). Increased weight loss was significantly associated with greater AF freedom: 45 (39%) in Group 1, 69 (67%) in Group 2, and 116 (86%) in Group 3 (P ≤ 0.001). Conclusion Obesity is associated with progression of the AF disease. This study demonstrates the dynamic relationship between weight/risk factors and AF. Weight-loss management and RFM reverses the type and natural progression of AF.
Journal of the American College of Cardiology | 2014
Rajeev K. Pathak; M. Middeldorp; Dennis H. Lau; A. Mehta; Rajiv Mahajan; D. Twomey; M. Alasady; Lorraine Hanley; Nicholas Alexander Antic; R. D. McEvoy; Jonathan M. Kalman; Walter P. Abhayaratna; Prashanthan Sanders
JACC: Clinical Electrophysiology | 2017
Rajeev K. Pathak; Michelle Evans; M. Middeldorp; Rajiv Mahajan; A. Mehta; Megan Meredith; D. Twomey; Christopher X. Wong; Jeroen Hendriks; Walter P. Abhayaratna; Jonathan M. Kalman; Dennis H. Lau; Prashanthan Sanders
Heart Lung and Circulation | 2016
M. Evans; Rajeev K. Pathak; M. Middeldorp; Rajiv Mahajan; A. Mehta; M. Meredith; D. Twomey; Christopher X. Wong; Jeroen Hendriks; Walter P. Abhayaratna; J. Kalman; Dennis H. Lau; P. Sanders
Journal of the American College of Cardiology | 2015
Rajeev K. Pathak; A. Mehta; Dennis H. Lau; Prashanthan Sanders
Heart Lung and Circulation | 2015
Rajeev K. Pathak; M. Evans; M. Middeldorp; A. Mehta; Walter P. Abhayaratna; Dennis H. Lau; Prashanthan Sanders
Heart Lung and Circulation | 2015
Rajeev K. Pathak; J. Sen; A. Mehta; Christopher X. Wong; M. Alasady; Dennis H. Lau; Walter P. Abhayaratna; Prashanthan Sanders
Heart Lung and Circulation | 2015
Rajeev K. Pathak; Adam J. Nelson; M. Meredith; Angelo Carbone; A. Mehta; K. Teo; K. Williams; Rajiv Mahajan; D. Twomey; Dennis H. Lau; Walter P. Abhayaratna; Prashanthan Sanders